Financial performances Comparison is as follows: THB’000 Consolidated ∆% Separate ∆% Q1/2019 Q1/2018 Q1/2018 Q1/2017 Revenues from sales and services of medical equipment 460,711 366,698 26% 382,283 320,648

Q2/2019 ∆% Q1/2020 ∆% Revenues from sales of medical equipment and services 431,618 440,596 -2% 301,848 43% Revenues from sales and beauty treatment services 3,568 43,985 -92% 22,202 -84% Interest

office buildings and the Machinery purchase agreement with Golden Arrow Coating Co., Ltd. of which Mr. Arkran Termritikulchai and Mr. Pasithphol Termritikulchai who are its Directors and are sons of Mr

5,576,858 5,573,375 3,483 0.1 Directors’ remuneration 47,311 46,688 623 1.3 Premises and equipment expenses 1,300,008 1,163,974 136,034 11.7 Taxes and duties 427,193 392,544 34,649 8.8 Loss from revaluation

decrease in premises and equipment expenses. Cost-to-income ratio excluding loss from sale and revaluations of foreclosed assets stood at 38.4% improving from 40.2% during 1Q20. Unit: Baht million 1Q21 4Q20

depreciation of plant and machinery that contributed to higher share of cost of goods sold. In addition, the Company executed sales promotional campaigns for slow moving inventories that accounted for lower

price at amount of Baht 108.99 million increased from ended 31 December 2017. 6. The subsidiaries’ property, plant and equipment increased by Baht 336.31 million from the factory which is under

electronics and machinery and equipment that can return to expand Meanwhile, motor vehicles and parts contracted less and manufacturing production contracted less due to improved production in almost all

, operating profit would decrease by Baht 75.3 million or 45.6% if excluding the write-off of plant and equipment from the renovation of River Wing building amount of Baht 79.0 million. For expenditures, the

equipment from abroad and/or purchase software programs using in EA's solar power plant construction project through the aforementioned two subsidiaries. The acts of 2 persons mentioned above were